Lv456
510 积分 2026-01-23 加入
HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
1个月前
已完结
Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis
1个月前
已完结
Clinical characteristics and genetic analysis of childhood acute lymphoblastic leukemia with hemophagocytic lymphohistiocytosis: a Japanese retrospective study by the Kyushu–Yamaguchi Children’s Cancer Study Group
1个月前
已完结
Malignancy-associated haemophagocytic lymphohistiocytosis
1个月前
已完结
Pediatric hemophagocytic lymphohistiocytosis: current conceptualization, diagnosis, and treatment
1个月前
已完结
Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemia
1个月前
已完结
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
1个月前
已完结
Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia
1个月前
已完结
Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemia
1个月前
已完结
CD19 expression in pediatric patients with relapsed/refractory B‐cell precursor acute lymphoblastic leukemia pre‐ and post‐treatment with blinatumomab
1个月前
已完结
皖公网安备34019202002308
